|
[1]Edward L K.Autoimmune hepatitis[J].N Engl J Med, 2006, 354 (1) ∶54-66.
|
|
[2]Michael P, Manns, Arndt V.Autoimmune hepatitis, from mecha-nisms to therapy[J].Hepatology, 2006, 43 (2) ∶132-144.
|
|
[3]Strassburg CP, Manns MP.Autoantibodies and autoantigens in auto-immune hepatitis[J].Semin Liver Dis, 2002, 22 (6) ∶339-352.
|
|
[4]Czaja AJ, Shums Z, Donaldson PT, et al.Frequency and signifi-cance of antibodies to Saccharomyces cerevisiae in autoimmune hepa-titis[J].Dig Dis Sci, 2004, 49 (10) ∶611-618.
|
|
[5]Liaskos C, Rigopoulou E, Zachou K, et al.Prevalence and clinicalsignificance of anticardiolipin antibodies in patients with type 1 auto-immune hepatitis[J].J Autoimmun, 2005, 24 (4) ∶251-260.
|
|
[6]Djilali-SaiahⅠ, Renous R, Caillat-Zucman, et al.Linkage dise-quilibrium between HLAclass region and autoimmune hepatitis in pe-diatric patients[J].J Hepatol, 2004, 40 (11) ∶904-909.
|
|
[7]Donaldson PT.Genetics in autoimmune hepatitis[J].Semin LiverDis, 2002, 22 (8) ∶353-364.
|
|
[8]Ueda H, Howson JM, Esposito L, et al.Association of the T-cellregulatory gene CTLA4 with susceptibility to autoimmunedisease[J].Nature, 2003, 423 (9) ∶506-511.
|
|
[9]Hiraide A, Imazeki F, Yokosuka O, et al.Fas polymorphisms influ-ence susceptibility to autoimmune hepatitis[J].Am J Gastroenterol, 2005, 100 (10) ∶1322-1329.
|
|
[10]Fan LY, Tu XQ, Zhu Y, et al.Genetic association of cytokinespolymorphisms with autoimmune hepatitis and primary biliary cirrho-sis in the Chinese[J].World J Gastroenterol, 2005, 11 (12) ∶2768-2772.
|
|
[11]Fan L, Tu X, Zhu Y, et al.Genetic association of vitamin D recep-tor polymorphisms with autoimmune hepatitis and primary biliary cir-rhosis in the Chinese[J].J Gastroenterol Hepatol, 2005, 20 (6) ∶249-255.
|
|
[12]Vogel A, Strassburg CP, Manns MP.77C/G mutation in the tyro-sine phosphatase CD45 gene and autoimmune hepatitis:evidence fora genetic link[J].Genes Immun, 2003, 4 (1) ∶79-81.
|
|
[13]Feld JJ, Dinh H, Arenovich T, et al.Autoimmune hepatitis:effectof symptoms and cirrhosis on natural history and outcome[J].Hepa-tology, 2005, 42 (1) ∶53-62.
|
|
[14]Czaja AJ.Treatment strategies in autoimmune hepatitis[J].ClinLiver Dis, 2002, 6 (9) ∶511-536.
|
|
[15]Fernandes NF, Redeker AG, Vierling JM, et al.Cyclosporine ther-apy in patients with steroid resistant autoimmune hepatitis[J].Am JGastroenterol, 1999, 94 (5) ∶241-248.
|
|
[16]Kaplan M, Gershwin M.Primary biliary cirrhosis[J].N Engl JMed, 2005, 353 (9) ∶1261-1273.
|
|
[17]Duclos-Vallee JC, Sebagh M, Rifai K, et al.A10 year followupstudy of patients transplanted for autoimmune hepatitis:histologicalrecurrence precedes clinical and biochemical recurrence[J].Gut, 2003, 52 (6) ∶893-897.
|
|
[18]Mieli-Vergani G, Vergani D.De novo autoimmune hepatitis afterliver transplantation[J].J Hepatol, 2004, 40 (1) ∶3-7.
|
|
[19]Inui A, Sogo T, Komatsu H, et al.Antibodies against cytokeratin8/18 in a patient with de novo autoimmune hepatitis after living-do-nor liver transplantation[J].Liver Transpl, 2005, 11 (5) ∶504-507.
|
PDF下载 ( 98 KB)
本文二维码
下载:
